Clinical Report: Non-ST-Elevation Myocardial Infarction Following Fluorescein Angiography
Overview
This report describes a rare case of non-ST-elevation myocardial infarction (NSTEMI) following fluorescein angiography in a 76-year-old woman. It highlights the need for clinical vigilance and preparedness for managing serious complications associated with this common ophthalmic procedure.
Background
Fluorescein angiography (FA) is a widely used diagnostic tool for assessing retinal vasculature, but it carries a risk of serious adverse reactions, including myocardial infarction. Understanding the potential for such complications is crucial for healthcare providers to ensure patient safety and effective management during and after the procedure.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
A 76-year-old woman developed NSTEMI shortly after undergoing fluorescein angiography.
She had a history of hypertension, hyperlipidemia, and type 2 diabetes mellitus.
Cardiac catheterization revealed an occlusion of the right coronary artery.
Possible mechanisms for NSTEMI included allergic-mediated coronary vasospasm or catecholamine release.
Severe complications from FA are rare, occurring in less than 1% of cases.
Thorough patient counseling and institutional readiness are essential for managing emergencies related to FA.
Clinical Implications
Healthcare providers should be aware of the potential for serious cardiovascular events following fluorescein angiography, particularly in patients with pre-existing conditions. Adequate patient counseling and emergency preparedness are vital to mitigate risks associated with this procedure.
Conclusion
This case underscores the importance of vigilance in monitoring patients during fluorescein angiography and highlights the need for readiness to address acute complications such as NSTEMI.
